I like your thinking.
Patience is required. It takes more than 9 months to design/validate new product, establish/launch a mfg base, identify/penetrate new markets and finally record sales and generate FCF. Moreover, doing this without significant funding and simultaneously challenging a Fortune 50 concern to stay afloat. Hopefully the principle based approach will win out.
The noise on this board should not deter the l-t approach. I have personally spoken to the CEO and I have skin in the gsme and will be patient to see it thru. It's an OTC stock with many risks. It's also a stock that generates polarized opinions. Time will tell which camp is right, the rest is just opinion and clutter.